We are live on ! Find out more
FCM

Farallon Capital Management Portfolio holdings

AUM $21.7B
1-Year Est. Return 79.24%
This Fund
S&P 500
This Quarter Est. Return
+18.01%
1 Year Est. Return
+79.24%
3 Year Est. Return
+204.51%
5 Year Est. Return
+270.91%
10 Year Est. Return
+1,884.18%
AUM
$23.1B
AUM Growth
-$1.32B
Cap. Flow
-$3.13B
Cap. Flow %
-13.54%
Top 10 Hldgs %
44.45%
Holding
175
New
31
Increased
22
Reduced
37
Closed
21

Top Buys

Rank Stock Value
1
EA
Electronic Arts
EA
+$1.02B
2
EXAS
Exact Sciences
EXAS
+$514M
3
CYBR
CyberArk
CYBR
+$507M
4
SNPS icon
Synopsys
SNPS
+$444M
5
AVGO icon
Broadcom
AVGO
+$319M

Top Sells

Rank Stock Value
1
ADSK icon
Autodesk
ADSK
+$528M
2
TMO icon
Thermo Fisher Scientific
TMO
+$352M
3
TRU icon
TransUnion
TRU
+$333M
4
INTU icon
Intuit
INTU
+$333M
5
K
Kellanova
K
+$323M

Sector Composition

Rank Sector Weight
1 Healthcare 41.06%
2 Technology 12.67%
3 Financials 9.75%
4 Communication Services 8.88%
5 Consumer Discretionary 4.5%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
WELL icon
51
Welltower
WELL
$174B
$63.7M 0.28%
+343,000
New +$64.1M
TRU icon
52
TransUnion
TRU
$16.2B
$57.9M 0.25%
675,000
-4,057,075
-86% -$333M
TYRA icon
53
Tyra Biosciences
TYRA
$1.56B
$54.3M 0.24%
2,066,818
+923,000
+81% +$17M
VNET
54
VNET Group
VNET
$1.88B
$53.2M 0.23%
6,285,386
+796,266
+15% +$7.38M
ABVX
55
Abivax
ABVX
$10.2B
$52.2M 0.23%
387,000
-418,000
-52% -$45.6M
ENTA icon
56
Enanta Pharmaceuticals
ENTA
$412M
$43.7M 0.19%
2,772,262
+650,000
+31% +$8.26M
INSM icon
57
CALL
Insmed
INSM
$27.2B
$43.5M 0.19%
+250,000
New +$45.6M
ASMB icon
58
Assembly Biosciences
ASMB
$721M
$41.8M 0.18%
1,227,590
– –
BIDU icon
59
Baidu
BIDU
$31.6B
$41.2M 0.18%
315,300
+107,304
+52% +$13.3M
ALNY icon
60
PUT
Alnylam Pharmaceuticals
ALNY
$32B
$39.8M 0.17%
100,000
– –
JOYY
61
JOYY Inc
JOYY
$3.77B
$37.4M 0.16%
578,200
-46,800
-7% -$2.86M
ETHA
62
iShares Ethereum Trust ETF
ETHA
$7.68B
$33.2M 0.14%
1,481,001
-5,969,729
-80% -$156M
GPCR icon
63
Structure Therapeutics
GPCR
$3.52B
$31.6M 0.14%
+454,000
New +$18.5M
MLYS icon
64
Mineralys Therapeutics
MLYS
$2.29B
$29.9M 0.13%
823,296
-849,757
-51% -$34.1M
SUNC
65
SunocoCorp LLC
SUNC
$3.93B
$29.9M 0.13%
+606,277
New +$30.5M
PCSC
66
DELISTED
Perceptive Capital Solutions
PCSC
$29.3M 0.13%
+2,250,000
New +$26.2M
TERN
67
DELISTED
Terns Pharmaceuticals
TERN
$25.9M 0.11%
+642,000
New +$14.8M
EHC icon
68
Encompass Health
EHC
$11.9B
$24.9M 0.11%
234,500
-336,500
-59% -$39M
AMKR icon
69
Amkor Technology
AMKR
$12B
$18.3M 0.08%
+464,000
New +$16.5M
VSTM icon
70
Verastem
VSTM
$669M
$15.4M 0.07%
+2,000,000
New +$17.8M
DOCS icon
71
Doximity
DOCS
$4.41B
$13.8M 0.06%
311,000
-63,000
-17% -$3.54M
GH icon
72
Guardant Health
GH
$22.9B
$11.1M 0.05%
109,000
+101,000
+1,263% +$9.04M
MDLN
73
Medline Inc
MDLN
$30.3B
$10.9M 0.05%
+260,000
New +$11M
EDU icon
74
New Oriental
EDU
$9.19B
$10.8M 0.05%
196,000
-369,150
-65% -$20.2M
NERV icon
75
Minerva Neurosciences
NERV
$259M
$9.51M 0.04%
+2,365,000
New +$8.78M
1 2
3
4 5

Similar funds

BG
Bahl & Gaynor Cincinnati, Ohio $21.7B AUM 30.58% 1-Year Est. Return
IC
IEQ Capital Foster City, California $21.7B AUM 77.3% 1-Year Est. Return
OSAM
O'Shaughnessy Asset Management Stamford, Connecticut $21.7B AUM 41.93% 1-Year Est. Return
SA
Sanctuary Advisors Indianapolis, Indiana $21.6B AUM 28.31% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $21.5B AUM 23.65% 1-Year Est. Return
CHP
Castle Hook Partners New York $21.8B AUM 215.45% 1-Year Est. Return
PAG
Private Advisor Group Morristown, New Jersey $21.8B AUM 28.57% 1-Year Est. Return
ETC
Exchange Traded Concepts Oklahoma City, Oklahoma $21.9B AUM 68.6% 1-Year Est. Return

Farallon Capital Management's Q4 2025 Portfolio in Review

As of Q4 2025, Farallon Capital Management held 175 positions worth $23.1B, down 5.4% from $24.4B the previous quarter. Its ten largest holdings account for 44% of the portfolio.

Farallon Capital Management withdrew a net $3.13B in Q4 2025, closing 21 positions and reducing 37 holdings. Its most notable exit was Autodesk, an estimated $528M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 41% of assets, up from 33% a quarter earlier, followed by Technology and Financials.

Against the trend, Farallon Capital Management opened a new position in Electronic Arts worth $1.03B.

  • Farallon Capital Management's largest Q4 2025 buy was Electronic Arts: 5,035,000 shares worth $1.03B.
  • Farallon Capital Management added most to Boston Scientific in Q4 2025, an estimated $264M increase.
  • Farallon Capital Management's biggest Q4 2025 reduction was Thermo Fisher Scientific, cutting an estimated $352M.
  • Farallon Capital Management fully exited Autodesk in Q4 2025, selling an estimated $528M.
  • Farallon Capital Management's ten largest holdings make up 44% of its $23.1B portfolio in Q4 2025.
  • Farallon Capital Management opened 31 new positions and closed 21 in Q4 2025.
  • Farallon Capital Management's portfolio value fell 5.4% quarter-over-quarter to $23.1B.

Based on Farallon Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.